Results 1 to 10 of about 11,680 (225)

Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity. [PDF]

open access: yesPLoS ONE, 2013
BackgroundThere are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that
Yusuf Y Deeni   +4 more
doaj   +6 more sources

A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy [PDF]

open access: yesFrontiers in Medicine, 2018
Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases.
Sally H. Ibbotson
doaj   +5 more sources

Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports [PDF]

open access: yesTherapeutic Advances in Hematology
This report describes the cases of two patients with mycosis fungoides and Sézary syndrome (MF/SS) who achieved clinical benefit with mogamulizumab combination therapies.
Andrea Bernardelli, Carlo Visco
doaj   +2 more sources

SOAP PUVA

open access: yesIndian Dermatology Online Journal, 2018
C R Srinivas, C Shanmuga Sekar
doaj   +3 more sources

The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin

open access: yesMicroorganisms, 2023
Inactivated whole-cell vaccines present a full repertoire of antigens to the immune system. Formalin treatment, a standard method for microbial inactivation, can modify or destroy protein antigenic epitopes.
Marlena M. Westcott   +6 more
doaj   +1 more source

Phototherapy

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2022
Considering its effects, side effects, and contraindications, phototherapy is a treatment option that can be used in patients who do not respond to topical treatments, suffer side effects, or have diffuse lesions.
Melih Akyol
doaj   +1 more source

Bath Psoralen Plus UVA Therapy Suppresses Keratinocyte-Derived Chemokines in Pathogenetically Relevant Cells

open access: yesJID Innovations, 2021
Psoriasis is a chronic inflammatory proliferative skin disease involving various types of chemokines regulating immune cell migration, localization, and activation. Bath psoralen plus UVA (PUVA) treatment is an established phototherapy for psoriasis, but
Yoshifumi Kanayama   +3 more
doaj   +1 more source

Phototherapy combined with systemic agents for mycosis fungoides [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2023
The choice of tactics for managing a patient with mycosis fungoides is determined by the stage of the disease. In the early stages of mycosis fungoides, a treatment approach using external therapy and various ultraviolet irradiation spectra (UVB-311 nm ...
Anastasiia A. Vorontsova   +1 more
doaj   +1 more source

Comparative Effectiveness and Safety of Methotrexate Versus PUVA in Severe Chronic Stable Plaque Psoriasis

open access: yesIndian Journal of Dermatology, 2021
Background: Psoriasis is a chronic, inflammatory, immune-mediated, debilitating skin disease affecting approximately 2%–3% of the global population.
Saikat Banerjee   +3 more
doaj   +1 more source

Subungual Squamous Cell Carcinoma in a Patient with Psoriasis

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2020
Subungual squamous cell carcinoma (SCC) is a rare malignant tumour with an indolent course and unknown aetiology. It is usually misdiagnosed as a benign lesion, resulting in delayed treatment.
Sherif Monib, Kevin Seebah
doaj   +1 more source

Home - About - Disclaimer - Privacy